AGP Executive Report
Last update: 2 hours agoMedical Innovation in Italy: Aptar Pharma and Aceso Therapeutics announced a collaboration to advance ACT-101, an inhaled antisense therapy candidate for cystic fibrosis, with Nanopharm supporting formulation and device work. Food Safety Alert: The U.S. USDA issued a Class I recall of imported ready-to-eat pork guanciale (about 1,513 pounds) after possible Listeria monocytogenes contamination; no illnesses reported, but consumers and retailers are told not to eat or sell the affected lots. Public Health & Longevity Buzz: A new wave of “immortality” and longevity research is highlighted, from cellular reprogramming and repurposed drugs to wearables estimating “biological age,” as biotech investment in aging reversal keeps accelerating. Health Tech & Care at Home: A review reports that game-based telerehabilitation can help physical therapy for multiple sclerosis patients, pointing to more engaging remote rehab options. Climate/Health Context: Italy’s schools are pushing to delay the start of term amid heatwave conditions, underscoring how rising temperatures are reshaping everyday health decisions.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.